- Home
- UWMC vs OCS Comparison
UWMC vs OCS Comparison
Compare UWMC & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UWMC | OCS |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | UWMC | OCS |
|---|---|---|
| Price | $4.57 | $20.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $6.63 | ★ $39.57 |
| AVG Volume (30 Days) | ★ 11.2M | 114.7K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | ★ 8.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $2,703,097,000.00 | $991,999.00 |
| Revenue This Year | $17.46 | $14.53 |
| Revenue Next Year | $22.09 | $691.13 |
| P/E Ratio | $78.46 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.80 | $14.00 |
| 52 Week High | $7.14 | $23.08 |
Technical Indicators
Market Signals| Indicator | UWMC | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 28.75 | 54.68 |
| Support Level | $4.74 | $20.18 |
| Resistance Level | $4.96 | $21.33 |
| Average True Range (ATR) | 0.19 | 0.72 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 1.57 | 54.38 |
Price Performance
Historical ComparisonAbout UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.